ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,052.51
-0.04%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) Noticias

LQDA

Liquidia (LQDA)

Liquidia Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LQDA
FechaHoraFuenteTítuloSímboloCompañía
14/05/202415:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
13/05/202416:43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
13/05/202416:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
10/05/202407:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
07/05/202407:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
07/05/202407:00GlobeNewswire Inc.Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:LQDALiquidia Corporation
02/04/202408:00GlobeNewswire Inc.Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
01/04/202405:00GlobeNewswire Inc.Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
13/03/202405:00GlobeNewswire Inc.Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
06/03/202405:30GlobeNewswire Inc.Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:LQDALiquidia Corporation
04/03/202418:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
30/01/202405:30GlobeNewswire Inc.Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual CongressNASDAQ:LQDALiquidia Corporation
25/01/202405:00GlobeNewswire Inc.Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
19/01/202405:30GlobeNewswire Inc.Liquidia Corporation Announces Updates to Operations LeadershipNASDAQ:LQDALiquidia Corporation
16/01/202406:42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LQDALiquidia Corporation
08/01/202407:22GlobeNewswire Inc.Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files CounterclaimsNASDAQ:LQDALiquidia Corporation
05/01/202405:45GlobeNewswire Inc.Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
04/01/202408:10GlobeNewswire Inc.Liquidia Corporation Announces $100 Million in New FinancingsNASDAQ:LQDALiquidia Corporation
03/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
02/01/202405:45GlobeNewswire Inc.Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
28/12/202315:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LQDALiquidia Corporation
22/12/202315:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LQDALiquidia Corporation
20/12/202315:56GlobeNewswire Inc.U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)NASDAQ:LQDALiquidia Corporation
12/12/202315:41Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:LQDALiquidia Corporation
12/12/202306:13GlobeNewswire Inc.Liquidia Announces Pricing of Public Offering of Common StockNASDAQ:LQDALiquidia Corporation
07/11/202305:30GlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
31/10/202305:30GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:LQDALiquidia Corporation
02/10/202306:00GlobeNewswire Inc.Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of DirectorsNASDAQ:LQDALiquidia Corporation
25/09/202315:09GlobeNewswire Inc.FDA Accepts Submission to Add PH-ILD to YUTREPIA™ LabelNASDAQ:LQDALiquidia Corporation
06/09/202315:30GlobeNewswire Inc.United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent OfficeNASDAQ:LQDALiquidia Corporation
 Showing the most relevant articles for your search:NASDAQ:LQDA

Su Consulta Reciente

BIT
USDAX7
Unicredit Bank
UNSW
C42ETH
COIN
VIPLUSD
NASDAQ
TBKCP
Triumph Bancorp
TG
CAI
Canadian Imperial Bank O...
COIN
FISTEUR
LBNK
HZMUSDT
HZMCOIN
BIT
UV8CT0
UniCredit Bank
LSE
43RE
Inter-amer 39
USOTC
PRBM
Parabellum Acquisition (CE)
LSE
CCME
Rqfii Mm Etf
NASDAQ
FLJTLX
Dividend Strength Portfo...
ASX
ORIJOF
LSE
FSWD
Ish Msciwrld
LSE
41Q0
Investec Bnk 26
NASDAQ
LIPO
Lipella Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados